Overview

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Status:
Terminated

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

The primary objective of the study was to examine the safety and tolerability of memantine in outpatients with moderate to severe Alzheimer's Disease.

Phase:

Phase 3

Details

Lead Sponsor:

H. Lundbeck A/S

Treatments:

Memantine